Search
Jeffrey Jarman Ph.D., Tsongas Litigation
Oct 30, 2020
MEDICAL RISK ASSESSMENTS IN THE COVID-19 ERA: LESSONS FOR DRUG AND MEDICAL DEVICE DEFENDANTS
Originally published in Law360, June 12, 2020 As the COVID-19 pandemic drags on in the United States, there are potentially many changes...
Theodore O. Prosise Ph.D.
Aug 19, 2020
STRATEGICALLY APPROACHING NEW COVID-19 JURY SELECTION PROCEDURES
The priority of social distancing in the age of COVID-19 has led to innovations in trial practices, including substantial changes to how...
Alexis Knutson, Jeffrey Jarman Ph.D.
Aug 6, 2020
HOW FEDERAL PATENT TUTORIAL VIDEO INFLUENCES JURORS
The COVID-19 global pandemic has led to an unprecedented backlog of cases, and, as a result, courts are considering ways to alleviate the...
Christopher J. Dominic, Theodore O. Prosise
Jul 8, 2020
TRIAL CONSULTANTS AS KEY ASSETS IN MULTIDISTRICT LITIGATION
Managing the scope of multidistrict litigation (MDL) is a daunting task for attorneys and trial teams. The sheer number of cases,...
Jeffrey Jarman Ph.D., Tsongas Litigation
Jun 19, 2020
SHARING COVID-19 EFFORTS UNLIKELY TO CHANGE VERDICTS
Originally published in Law360, June 12, 2020 The COVID-19 pandemic has elicited a variety of responses by businesses trying to build or...
Laura L. Dominic
Jun 11, 2020
WHO MIGHT NOT BE ON YOUR JURY IN THE “NEW NORMAL” TRIAL?
As our country has started to reopen, we have heard a lot about the “new normal”. It appears inevitable that social distancing and mask...